INBX - Financial Reports List - Inhibrx Biosciences, Inc. - IntrinsicAlpha

Inhibrx Biosciences, Inc. INBX

Healthcare - Biotechnology - NASDAQ - US

$ 11.87

-0.785 %

$ 172 M

Market Cap

0.1

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-93.88%	48.86%	43.45%
Annual Report	FY	10-K	2024-12-31	-88.89%	799.19%	-51.19%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	15.30%	-2.12%
Quarterly Report	Q2	8-K	2024-06-30	233.33%	4048.85%	-289.22%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-61.65%	-68.68%
Quarterly Report	Q4	8-K	2023-12-31	496.35%	-128.78%	-148.70%
Annual Report	FY	10-K	2023-12-31	-17.36%	-66.20%	-69.78%
Quarterly Report	Q3	8-K	2023-09-30	-57.19%	-27.41%	-52.74%
Quarterly Report	Q2	8-K	2023-06-30	-95.78%	-24.70%	-19.49%
Quarterly Report	Q1	8-K	2023-03-31	-98.14%	-45.39%	-50.83%

1